BAX and familial pancreatic carcinoma: Previous studies have suggested that overexpression of CacyBP/SIP might inhibit drug-induced apoptosis by enhancing the Bcl-2/Bax ratio in pancreatic cancer cells (Xiong Chen, Apoptosis 2013).